PET Imaging of Solid Tumors Using 124I-Humanized 3F8: A Pilot Study
Latest Information Update: 06 Dec 2023
At a glance
- Drugs Naxitamab (Primary)
- Indications Ewing's sarcoma; Leiomyosarcoma; Liposarcoma; Malignant fibrous histiocytoma; Malignant melanoma; Medulloblastoma; Neuroblastoma; Osteosarcoma; Paraganglioma; Sarcoma; Small cell lung cancer; Solid tumours
- Focus Pharmacokinetics
- 01 Dec 2023 Planned End Date changed from 1 Nov 2023 to 1 Nov 2024.
- 01 Dec 2023 Planned primary completion date changed from 1 Nov 2023 to 1 Nov 2024.
- 01 Dec 2022 Planned End Date changed from 1 Nov 2022 to 1 Nov 2023.